ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,362Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 944

$618K Total Retail Price of All Prescriptions

Rank: 109 out of 944

556 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 556 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,362 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 674 468 1 2
SIMVASTATIN 521 424 2 1
AMLODIPINE BESYLATE 449 388 3 5
WARFARIN SODIUM 347 250 4 7
LISINOPRIL 342 237 5 3
OMEPRAZOLE 317 274 6 4
ATENOLOL 310 289 7 11
METOPROLOL TARTRATE 266 245 8 8
FUROSEMIDE 238 192 9 6
HYDROCHLOROTHIAZIDE 229 198 10 9
METFORMIN HCL 225 167 11 12
PRAVASTATIN SODIUM 207 163 12 17
LOSARTAN POTASSIUM 203 160 13 16
ALENDRONATE SODIUM 190 175 14 20
ATORVASTATIN CALCIUM 176 132 15 13
PANTOPRAZOLE SODIUM 165 89 16 34
TRAMADOL HCL 157 122 17 21
SERTRALINE HCL 153 137 18 23
POTASSIUM CHLORIDE 146 118 19 15
HYDROCODONE-ACETAMINOPHEN 140 123 S3 20 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 113 21 29
CITALOPRAM HBR 124 72 22 19
LOVASTATIN 123 97 23 26
GABAPENTIN 122 44 24 18
METOPROLOL SUCCINATE 115 86 25 14
ZOLPIDEM TARTRATE 109 85 26 25
CYMBALTA 102 73 27 75
CARVEDILOL 97 30 28 30
LOSARTAN-HYDROCHLOROTHIAZIDE 94 77 29 54
ADVAIR DISKUS 94 68 29 31
DONEPEZIL HCL 85 78 31 24
TRAZODONE HCL 84 45 32 45
NAMENDA 67 67 33 37
CRESTOR 66 55 34 28
ALLOPURINOL 65 50 35 22
FLUTICASONE PROPIONATE 64 34 36 40
DIGOXIN 63 36 37 39
LANTUS SOLOSTAR 61 35 38 61
SPIRIVA 61 41 38 65
DIOVAN HCT 59 59 40 108
LANTUS 58 49 41 46
NEXIUM 57 29 42 53
AMITRIPTYLINE HCL 57 35 R 42 79
NOVOLOG 56 39 44 93
FLUOXETINE HCL 55 45 45 48
RANITIDINE HCL 55 41 45 42
PROAIR HFA 54 28 47 56
CLOPIDOGREL 54 54 47 36
NORTRIPTYLINE HCL 53 27 49 204
OXYBUTYNIN CHLORIDE 52 46 50 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.